I have 20 years of experience in trading. I also have a extensive experience with drug development. I combine technical analysis, valuation of the company and the upcoming short term catalysts before trading. I will set a target price and very tight stop loss limits. I am an active trader and usually sell and jump in again in the same stock until it hits the target price. I like to take my profit after the little runs that the stocks have. It is a more conservative and profitable approach.
Learn More...
132
Total Recommendations
-2
Open Recommendations
26.12 %
Success Rate
1
Total Services
My Services
| Service Name | Avg % Return since Inception | Recommendations Open/Closed | % Success | YTD Return | Risk | Fees | |
|---|---|---|---|---|---|---|---|
| Biotechnology | -1.01 % | -2/134 | 26.12 % | 0.00 % | -4.95 | Free | Follow |
Closed Recommendations
| Symbol | Service | Type | Strategy | Created | Closed | % Return |
|---|---|---|---|---|---|---|
| AIMT | Biotechnology | Equity | Buy Long | 03/23/18 | 04/03/18 | -5.04 % |
| IDRA | Biotechnology | Equity | Buy Long | 01/26/18 | 04/02/18 | -9.57 % |
| ADMS | Biotechnology | Equity | Buy Long | 03/23/18 | 04/02/18 | -6.31 % |
| AVDL | Biotechnology | Equity | Buy Long | 03/23/18 | 03/27/18 | -4.26 % |
| PRTK | Biotechnology | Equity | Buy Long | 03/23/18 | 03/27/18 | -3.70 % |
| CDTX | Biotechnology | Equity | Buy Long | 03/23/18 | 03/26/18 | -9.09 % |
| CPRX | Biotechnology | Equity | Buy Long | 03/23/18 | 03/23/18 | -2.26 % |
| AKAO | Biotechnology | Equity | Buy Long | 01/02/18 | 03/23/18 | 19.40 % |
| ADXS | Biotechnology | Equity | Buy Long | 03/05/18 | 03/12/18 | 10.61 % |
| SGYP | Biotechnology | Equity | Buy Long | 12/13/17 | 03/05/18 | 11.11 % |
| LXRX | Biotechnology | Equity | Buy Long | 12/21/17 | 02/09/18 | -13.29 % |
| NLNK | Biotechnology | Equity | Buy Long | 01/12/18 | 02/06/18 | -6.54 % |
| PRTK | Biotechnology | Equity | Buy Long | 01/26/18 | 02/02/18 | -4.15 % |
| TTPH | Biotechnology | Equity | Buy Long | 01/11/18 | 02/01/18 | -15.38 % |
| QTNT | Biotechnology | Equity | Buy Long | 01/26/18 | 01/31/18 | -8.26 % |
| ADMP | Biotechnology | Equity | Buy Long | 12/21/17 | 01/29/18 | -14.61 % |
| ACRX | Biotechnology | Equity | Buy Long | 12/13/17 | 01/26/18 | 0.00 % |
| RNN | Biotechnology | Equity | Buy Long | 10/25/17 | 01/26/18 | 22.53 % |
| SCYX | Biotechnology | Equity | Buy Long | 01/12/18 | 01/16/18 | -2.63 % |
| KDMN | Biotechnology | Equity | Buy Long | 12/13/17 | 01/12/18 | 8.38 % |
| TLGT | Biotechnology | Equity | Buy Long | 01/11/18 | 01/12/18 | -4.95 % |
| TGTX | Biotechnology | Equity | Buy Long | 12/07/17 | 01/11/18 | 25.45 % |
| ARDM | Biotechnology | Equity | Buy Long | 01/04/18 | 01/09/18 | -21.88 % |
| OVAS | Biotechnology | Equity | Buy Long | 12/22/17 | 01/04/18 | -7.59 % |
| EYEG | Biotechnology | Equity | Buy Long | 12/13/17 | 01/03/18 | -9.92 % |
| ICPT | Biotechnology | Equity | Buy Long | 12/22/17 | 01/02/18 | -7.58 % |
| AKTX | Biotechnology | Equity | Buy Long | 10/25/17 | 12/22/17 | 4.05 % |
| RXII | Biotechnology | Equity | Buy Long | 11/30/17 | 12/21/17 | -15.91 % |
| KALA | Biotechnology | Equity | Buy Long | 11/10/17 | 12/13/17 | -7.81 % |
| EVOK | Biotechnology | Equity | Buy Long | 11/14/17 | 12/13/17 | -10.39 % |
| ACRX | Biotechnology | Equity | Buy Long | 12/07/17 | 12/12/17 | -9.09 % |
| LXRX | Biotechnology | Equity | Buy Long | 11/30/17 | 12/12/17 | -4.11 % |
| OVAS | Biotechnology | Equity | Buy Long | 11/30/17 | 12/12/17 | -9.40 % |
| SGYP | Biotechnology | Equity | Buy Long | 11/15/17 | 12/07/17 | -3.19 % |
| KDMN | Biotechnology | Equity | Buy Long | 11/03/17 | 12/07/17 | -4.23 % |
| CNAT | Biotechnology | Equity | Buy Long | 11/30/17 | 12/06/17 | -6.92 % |
| ARLZ | Biotechnology | Equity | Buy Long | 11/21/17 | 11/30/17 | -3.27 % |
| ICPT | Biotechnology | Equity | Buy Long | 11/21/17 | 11/28/17 | -3.77 % |
| TSRO | Biotechnology | Equity | Buy Long | 11/15/17 | 11/28/17 | -7.85 % |
| ZIOP | Biotechnology | Equity | Buy Long | 11/14/17 | 11/21/17 | 0.71 % |
| PTCT | Biotechnology | Options | Buy Puts | 10/12/17 | 11/17/17 | -96.43 % |
| PTCT | Biotechnology | Options | Buy Puts | 10/02/17 | 11/17/17 | -96.15 % |
| ADMP | Biotechnology | Equity | Buy Long | 10/18/17 | 11/15/17 | -10.00 % |
| ARDX | Biotechnology | Equity | Buy Long | 11/03/17 | 11/14/17 | -8.62 % |
| TSRO | Biotechnology | Equity | Buy Long | 11/14/17 | 11/14/17 | -1.54 % |
| IOVA | Biotechnology | Equity | Buy Long | 10/25/17 | 11/14/17 | 9.79 % |
| RDHL | Biotechnology | Equity | Buy Long | 11/10/17 | 11/14/17 | -4.49 % |
| TCON | Biotechnology | Equity | Buy Long | 11/03/17 | 11/13/17 | -6.78 % |
| AKAO | Biotechnology | Equity | Buy Long | 11/08/17 | 11/13/17 | -3.97 % |
| KERX | Biotechnology | Equity | Buy Long | 11/08/17 | 11/10/17 | -4.59 % |
| ZIOP | Biotechnology | Equity | Buy Long | 11/08/17 | 11/10/17 | -5.06 % |
| ATNM | Biotechnology | Equity | Buy Long | 10/11/17 | 11/08/17 | -16.38 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/29/17 | 11/08/17 | 8.26 % |
| NVTA | Biotechnology | Equity | Buy Long | 11/03/17 | 11/07/17 | -3.73 % |
| TGTX | Biotechnology | Equity | Buy Long | 10/19/17 | 11/03/17 | 3.90 % |
| MNOV | Biotechnology | Equity | Buy Long | 10/10/17 | 10/27/17 | 7.61 % |
| KERX | Biotechnology | Equity | Buy Long | 10/26/17 | 10/27/17 | -3.00 % |
| ARDX | Biotechnology | Equity | Buy Long | 10/18/17 | 10/26/17 | -11.50 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/25/17 | 10/26/17 | -0.35 % |
| AKAO | Biotechnology | Equity | Buy Long | 10/11/17 | 10/25/17 | -4.90 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/19/17 | 10/25/17 | -3.66 % |
| RNN | Biotechnology | Equity | Buy Long | 10/13/17 | 10/25/17 | -13.88 % |
| LXRX | Biotechnology | Equity | Buy Long | 10/17/17 | 10/24/17 | -4.34 % |
| ACRS | Biotechnology | Equity | Buy Long | 10/17/17 | 10/23/17 | -1.75 % |
| TGTX | Biotechnology | Equity | Buy Long | 10/18/17 | 10/18/17 | -3.66 % |
| SGYP | Biotechnology | Equity | Buy Long | 10/17/17 | 10/18/17 | -5.19 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/12/17 | 10/18/17 | -1.21 % |
| TCON | Biotechnology | Equity | Buy Long | 10/03/17 | 10/17/17 | -13.04 % |
| QTNT | Biotechnology | Equity | Buy Long | 10/02/17 | 10/17/17 | -6.86 % |
| ALDX | Biotechnology | Equity | Buy Long | 10/04/17 | 10/16/17 | -7.38 % |
| ANTH | Biotechnology | Equity | Buy Long | 10/12/17 | 10/16/17 | -6.98 % |
| IMDZ | Biotechnology | Equity | Buy Long | 10/12/17 | 10/16/17 | -2.73 % |
| AXSM | Biotechnology | Equity | Buy Long | 10/02/17 | 10/13/17 | -7.08 % |
| ARDX | Biotechnology | Equity | Buy Long | 09/19/17 | 10/12/17 | 38.39 % |
| GBT | Biotechnology | Equity | Buy Long | 10/04/17 | 10/12/17 | 5.65 % |
| ACRX | Biotechnology | Equity | Buy Long | 08/05/17 | 10/12/17 | -13.79 % |
| AERI | Biotechnology | Equity | Buy Long | 10/02/17 | 10/11/17 | 20.97 % |
| TRVN | Biotechnology | Equity | Buy Long | 10/02/17 | 10/10/17 | -6.84 % |
| AXON | Biotechnology | Equity | Buy Long | 10/03/17 | 10/10/17 | -11.10 % |
| MTFB | Biotechnology | Equity | Buy Long | 09/19/17 | 10/04/17 | 33.49 % |
| HRTX | Biotechnology | Equity | Buy Long | 09/13/17 | 10/03/17 | 14.24 % |
| FLXN | Biotechnology | Equity | Buy Long | 09/29/17 | 10/03/17 | 9.74 % |
| NUVA | Biotechnology | Equity | Buy Long | 09/25/17 | 10/02/17 | 0.11 % |
| ANTH | Biotechnology | Equity | Buy Long | 09/29/17 | 09/29/17 | -4.11 % |
| ZGNX | Biotechnology | Equity | Buy Long | 09/05/17 | 09/29/17 | 134.40 % |
| RDHL | Biotechnology | Equity | Buy Long | 09/11/17 | 09/28/17 | 21.36 % |
| CATB | Biotechnology | Equity | Buy Long | 09/08/17 | 09/28/17 | 37.93 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/26/17 | 09/27/17 | -2.03 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/22/17 | 09/26/17 | -8.90 % |
| FLXN | Biotechnology | Equity | Buy Long | 09/08/17 | 09/25/17 | 7.63 % |
| TRVN | Biotechnology | Equity | Buy Long | 09/20/17 | 09/22/17 | -2.81 % |
| NBRV | Biotechnology | Equity | Buy Long | 09/20/17 | 09/22/17 | -2.28 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/14/17 | 09/20/17 | 21.88 % |
| IDRA | Biotechnology | Equity | Buy Long | 09/05/17 | 09/19/17 | 22.58 % |
| ACRS | Biotechnology | Equity | Buy Long | 09/11/17 | 09/18/17 | -4.92 % |
| RXDX | Biotechnology | Equity | Buy Long | 09/13/17 | 09/18/17 | 15.38 % |
| NBRV | Biotechnology | Equity | Buy Long | 09/13/17 | 09/15/17 | -7.06 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/13/17 | 09/14/17 | -4.76 % |
| TGTX | Biotechnology | Equity | Buy Long | 09/07/17 | 09/12/17 | -4.88 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/08/17 | 09/12/17 | -5.18 % |
| HZNP | Biotechnology | Equity | Buy Long | 08/14/17 | 09/11/17 | 13.91 % |
| ADMP | Biotechnology | Equity | Buy Long | 09/08/17 | 09/11/17 | -2.75 % |
| RDHL | Biotechnology | Equity | Buy Long | 09/08/17 | 09/11/17 | -3.42 % |
| PETX | Biotechnology | Equity | Buy Long | 08/30/17 | 09/08/17 | 11.54 % |
| AUPH | Biotechnology | Equity | Buy Long | 09/06/17 | 09/08/17 | 8.99 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | 0.41 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| NVTA | Biotechnology | Equity | Buy Long | 08/28/17 | 09/06/17 | -2.44 % |
| AUPH | Biotechnology | Equity | Buy Long | 09/01/17 | 09/05/17 | -2.48 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/31/17 | 09/05/17 | -2.32 % |
| FGEN | Biotechnology | Equity | Buy Long | 08/23/17 | 08/31/17 | 13.99 % |
| INSM | Biotechnology | Equity | Buy Long | 08/17/17 | 08/30/17 | 2.73 % |
| INSM | Biotechnology | Equity | Buy Long | 08/24/17 | 08/30/17 | -2.28 % |
| PGNX | Biotechnology | Equity | Buy Long | 08/10/17 | 08/30/17 | 22.80 % |
| KMDA | Biotechnology | Equity | Buy Long | 08/16/17 | 08/30/17 | 2.41 % |
| NVTA | Biotechnology | Equity | Buy Long | 08/22/17 | 08/24/17 | 6.05 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/22/17 | 08/23/17 | -3.45 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/14/17 | 08/21/17 | -3.66 % |
| OMER | Biotechnology | Equity | Buy Long | 08/16/17 | 08/21/17 | -5.60 % |
| ADMP | Biotechnology | Equity | Buy Long | 08/05/17 | 08/17/17 | 0.00 % |
| KMDA | Biotechnology | Equity | Buy Long | 08/14/17 | 08/15/17 | -5.49 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/05/17 | 08/14/17 | -14.05 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/10/17 | 08/11/17 | -2.59 % |
| VSTM | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -7.04 % |
| ARLZ | Biotechnology | Equity | Buy Long | 08/05/17 | 08/10/17 | -5.17 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -2.88 % |
| SRPT | Biotechnology | Equity | Buy Long | 08/05/17 | 08/10/17 | -3.34 % |
| ABIO | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -11.11 % |
| PGNX | Biotechnology | Equity | Buy Long | 08/05/17 | 08/09/17 | -7.09 % |
| ADMP | Biotechnology | Equity | Buy Long | 08/07/17 | 08/09/17 | -5.32 % |
| ABIO | Biotechnology | Equity | Buy Long | 08/05/17 | 08/09/17 | -12.82 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/05/17 | 08/07/17 | -2.72 % |
TRENDING ARTICLES
ASIA ECONOMICS: China Shares Rally as Trade Talks Continue
02/22/19The Shanghai Composite index climbed 52 points or 1 9 to 2 804 Friday ahead of the conclusion of U S China trade talks in Washington with media reports suggesting that Chinese Vice Premier Liu He will meet U S President Trump later in the day said Trading Economics Gains came in
Warren Buffett and the Insurance Business: A 52-Year Love Story
02/22/19On Feb 22 2019 it will be 52 years to the day since Warren Buffett took his first serious dive into the insurance business when Berkshire Hathaway NYSE BRK A NYSE BRK B entered into an agreement to acquire National Indemnity Company and another smaller insurer for 8
39 Million Americans Have Been in Debt for at Least 2 Years -- and This Is a Big Reason Why
02/22/19Americans are notorious for racking up credit card debt but new data from CreditCards com reveals a frightening statistic A good 39 million Americans have been carrying credit card debt for at least two years Meanwhile 14 of folks with credit card debt have been carrying a
Reliance Steel (RS) Earnings Lag, Sales Beat Estimates in Q4
02/22/19Reliance Steel amp Aluminum Co RS 160 posted profit of 85 6 million or 1 22 per share in the fourth quarter of 2018 down roughly 72 from 301 4 million or 4 09 in the year ago quarter The bottom line in the reported quarter was hurt by a hefty LIFO inventory expense
Donald Trump Was Done Paying Social Security Tax Before 2 a.m. on January 1
02/22/19No one enjoys paying taxes but the American public also understands that paying tax is what helps fund federal state and local government as well as supports local and broad based social programs arguably none of which is more important than Social Security Despite
Why Arista Networks Has More Upside Ahead in 2019
02/22/19Though 2018 ended on a sour note shares of cloud computing hardware provider Arista Networks NYSE ANET have been rallying on strong results It has become a leader in data center and related technology including 100G and the new 400G speed standards and the hardware
Walmart, Not Amazon, Was the Retail Disruptor in 2018
02/22/19Walmart Inc NYSE WMT had a monster 2018 holiday shopping season Though many news outlets fretted over disappointing retail sales results there was no such problem for the king of retail Comparable sales which combines foot traffic and average customer ticket size in the U
Air Lease (AL) Q4 Earnings Top on Fleet Growth, Revenues Lag
02/22/19Air Lease Corporation AL delivered better than expected earnings but lower than expected revenues in the fourth quarter of 2018 The company s earnings excluding 41 cents from non recurring items of 1 65 per share surpassed the Zacks Consensus Estimate of 1 35 The bottom line
How Much Damage Can 1 Bad Experience Cause a Brand?
02/22/19Consumers have more choices about nearly every purchase than they ve ever had before It s no longer necessary to visit a physical store to buy most things and for the vast majority of products shoppers can pick from multiple retailers on their phone or computer In some measure
Validea Peter Lynch Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s P E Growth Investor model based on the published strategy of Peter Lynch This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets The following are today s upgrades
Validea Martin Zweig Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s Growth Investor model based on the published strategy of Martin Zweig This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt The following are today s upgrades
Validea Kenneth Fisher Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s Price Sales Investor model based on the published strategy of Kenneth Fisher This value strategy rewards stocks with low P S ratios long term profit growth strong free cash flow and consistent profit margins The following are today s
Validea Joseph Piotroski Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s Book Market Investor model based on the published strategy of Joseph Piotroski This value quant strategy screens for high book to market stocks and then separates out financially sound firms by looking at a host of improving
Validea John Neff Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s Low PE Investor model based on the published strategy of John Neff This strategy looks for firms with persisten t earnings growth that trade at a discount relative to their earnings growth and dividend yield The following are today s
Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/22/2019
02/22/19The following are today s upgrades for Validea s Earnings Yield Investor model based on the published strategy of Joel Greenblatt This value model looks for companies with high return on capital and earnings yields The following are today s upgrades for Validea sEarnings Yield Investor